Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of FORUM Pharmaceuticals Inc. patents

List of FORUM Pharmaceuticals Inc. patents

List of NOF (defunct) patents

List of Allscripts patents

List of Veris Technologies patents

List of Techstars Class 265 - London 2021 T5 companies

List of companies in Synetro Group's investment portfolio

Patents where

Current Assignee

Name

is

FORUM Pharmaceuticals Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9550767 Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate	Patent 9550767 was granted and assigned to FORUM Pharmaceuticals Inc. on January, 2017 by the United States Patent and Trademark Office.	FORUM Pharmaceuticals Inc.	FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	9550767	January 24, 2017
	‌ US Patent 8946222 Phenoxymethyl heterocyclic compounds	Patent 8946222 was granted and assigned to FORUM Pharmaceuticals Inc. on February, 2015 by the United States Patent and Trademark Office.	FORUM Pharmaceuticals Inc.	FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	8946222	February 3, 2015
	‌ US Patent 9585877 Methods of maintaining, treating or improving cognitive function	Patent 9585877 was granted and assigned to FORUM Pharmaceuticals Inc. on March, 2017 by the United States Patent and Trademark Office.	FORUM Pharmaceuticals Inc.	FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	9585877	March 7, 2017
	‌ US Patent 9265767 1,2-disubstituted heterocyclic compounds	Patent 9265767 was granted and assigned to FORUM Pharmaceuticals Inc. on February, 2016 by the United States Patent and Trademark Office.	FORUM Pharmaceuticals Inc.	FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	9265767	February 23, 2016
	‌ US Patent 8933074 1,2-disubstituted heterocyclic compounds	Patent 8933074 was granted and assigned to FORUM Pharmaceuticals Inc. on January, 2015 by the United States Patent and Trademark Office.	FORUM Pharmaceuticals Inc.	FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	8933074	January 13, 2015
	‌ US Patent 9273044 Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate	Patent 9273044 was granted and assigned to FORUM Pharmaceuticals Inc. on March, 2016 by the United States Patent and Trademark Office.	FORUM Pharmaceuticals Inc.	FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	9273044	March 1, 2016
	‌ US Patent 8815933 Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof	Patent 8815933 was granted and assigned to FORUM Pharmaceuticals Inc. on August, 2014 by the United States Patent and Trademark Office.		FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	8815933	August 26, 2014
	‌ US Patent 9108961 Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride	Patent 9108961 was granted and assigned to FORUM Pharmaceuticals Inc. on August, 2015 by the United States Patent and Trademark Office.		FORUM Pharmaceuticals Inc.		United States Patent and Trademark Office	9108961	August 18, 2015

8 results

0 selected

8 results

0 selected